📰 Breakthrough Devices Program News
Page 9 - Breakthrough Devices Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Breakthrough Devices Program. Real-time updates on events, politics, business and more.
July 12, 2022
Designation Allows for Expedited Review of Transcatheter Therapy Designed to Improve Left Ventricular Structure and Function in Heart Failure Patients with Reduced Ejection FractionSANTA CLARA, Calif.--(BUSINESS WIRE)--#accucinch--Ancora Heart, Inc., a company developing a novel device-based therapy to address heart...
July 11, 2022
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme PanelMolecular Diagnostic Test for Early Detection of Lyme Disease - read this article along with other careers information, tips and advice on BioSpace
June 23, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
June 22, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
June 22, 2022
Breakthrough Status allows for enhanced interaction with FDA and recognizes SonoCloud system as innovative and promising approach for treatment of recurrent glioblastoma Paris, France, June 22, 2022 – Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to tre...
May 23, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 23, 2022
Investigators Report Positive Findings From Feasibility Study of CCM in Heart Failure With Preserved Ejection Fraction at the European Society of...
May 23, 2022
Late-breaking Results Show Efficacy for CCM in Patients With HFpEF Investigators Report Positive Findings From Feasibility Study of CCM in Heart Failure With Preserved Ejection Fraction at the European Society of Cardiology Heart Failure 2022 Congress GlobeNewswire May 23, 2022 MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics,...
May 18, 2022
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005313/en/ Exactech Announces FDA Breakthrough Device Designation for
May 17, 2022
Designation to promote more rapid Agency and market access for VenoStentHOUSTON, TX / ACCESSWIRE / May 17, 2022 / VenoStent, Inc., a clinical-stage tissue engineering company developing bioabsorbable perivascular